Findev Inc. (FDI) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Findev Inc.

BRIEF

published on 11/15/2024 at 00:32, 6 days 10 hours ago

Findev Inc. Declares Upcoming Dividends

Shareholders Toronto Dividends Real Estate Finance Findev Inc.
PRESS RELEASE

published on 11/15/2024 at 00:27, 6 days 10 hours ago

Findev Inc. Announces Dividend
Findev Inc. declares dividends for shareholders on December 19, 2024 and March 27, 2025. Cumulative capital returned to shareholders highlighted, designated as eligible dividends under Income Tax Act (Canada). Future dividends subject to Board's discretion. Findev focuses on financing real estate developers in the Greater Toronto Area and special situation loans, providing expertise and unique market advantages

Shareholders Toronto Dividends Real Estate Finance Findev Inc.
BRIEF

published on 06/28/2024 at 18:05, 4 months 22 days ago

Findev Inc. Announces AGM Results

Incentive Stock Option Plan AGM Results Findev Inc. Shareholders' Voting Directors Re-elected
PRESS RELEASE

published on 06/28/2024 at 18:00, 4 months 22 days ago

Findev Inc. Announces AGM Results
Findev Inc. held its Annual General Meeting in Toronto with shareholders voting on re-electing directors, auditors, and stock option plan renewal. Details on voting results and shareholders' participation

Annual General Meeting Shareholders Voting Results Findev Inc. External Auditors
BRIEF

published on 04/15/2024 at 15:35, 7 months 5 days ago

Findev Inc. Announces Upcoming Dividends for 2024

Shareholder Returns Financial Compliance Findev Inc. 2024 Dividends Tax Eligible Dividends
PRESS RELEASE

published on 04/15/2024 at 15:30, 7 months 5 days ago

Findev Inc. Announces Dividend
Findev Inc. announces dividend declaration for June and September 2024, making cumulative capital returned to shareholders. The corporation's focus on real estate financing highlighted

Publicly Traded Company Dividend Declaration Real Estate Financing Findev Inc. Cumulative Capital Returned
PRESS RELEASE

published on 06/27/2023 at 16:15, 1 year 4 months ago

Findev Inc. Announces AGM Results
PRESS RELEASE

published on 05/08/2023 at 16:15, 1 year 6 months ago

Findev Inc. Announces Dividend

Accesswire

Published on 11/21/2024 at 10:03, 56 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 59 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 59 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 24 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 34 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 28 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 54 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 56 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 58 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 58 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 1 minute ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 38 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 14 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 14 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE